Radical prostatectomy (RP) represents the most frequently chosen therapeutic option for treating newly diagnosed localized prostate cancer. Cancer recurrence after surgery is linked to biologic variables. But are these the only ones that must be considered to give an explanation of a possible local or distal recurrence, or can it also admit the possibility that an incorrectly conducted surgery has a negative role in the unfavorable evolution after PR? Prostate cancer recurrence, as a matter of fact, is related also to surgical technique. The PR, by definition is a surgical, potentially complicated act. Surgery outcomes depend on a whole serires of factors: the surgeon's ability, and the way the surgical procedure is conducted, play an essential role. Here we evaluate the role of biological and surgical factors on biochemical recurrence.
IsbarnH., WannerM., SalomonG., SteuberT., SchlommT., KöllermannJ., SauterG., HaeseA., HeinzerH., HulandH., GraefenM.Long-term data on the survival of patients with prostate cancer treated with radical prostatectomy in the prostate-specific antigen era.BJU Int.2010 Jul; 106: 37–43.
2.
KupelianP., KatcherJ., LevinH., ZippeC., KleinE.Correlation of clinical and pathologic factors with rising prostate-specific antigen profiles after radical prostatectomy alone for clinically localized prostate cancer.Urology1996; 48: 249–60.
NosnikI.P., GanT.J., MoulJ.W.Open radical retropubic prostatectomy 2007: the true minimally invasive surgery for localized prostate cancer?Expert Rev Anticancer Ther2007; 7: 1309–17.
9.
UngJ.O., RichieJ.P., ChenM.H., RenshawA.A., D'AmicoA.V.Evolution of the presentation and pathologic and biochemical outcomes after radical prostatectomy for patients with clinically.Urology2002; 60: 458–63.
10.
StimacG., DimanovskiJ., TrnskiD., KatusiJ., RuziB., SpajiB., ReljiA., PadovanM., KrausO.Evolution of the clinical presentation and outcomes after radical prostatectomy for patients with clinically localized prostate cancer–changing trends over a ten year period.Coll Antropol2007; 31: 1055–60.
11.
HullG.W., RabbaniF., AbbasF., WheelerT.M., KattanM.W., ScardinoP.T.Cancer control with radical prostatectomy alone in 1000 consecutive patients.J Urol2002; 167: 528–34.
12.
AmlingC., BluteM.L., LernerS.E., BergstrahlE.J., BostwickD.G., ZinckeH.Influence of prostate specific antigen testing on the spectrum of patients with prostate cancer undergoing radical prostatectomy at large referral practice.Mayo Clin Proc1998; 73: 401–6.
13.
CatalonaW.J., SmithD.S., OrnsteinD.K.Prostate Cancer Detection in Men With Serum PSA Concentrations of 2.6 to 4.0 ng/mL and Benign Prostate Examination. Enhancement of Specificity. With Free PSA Measurements.JAMA.1997; 277(18): 1452–1455.
14.
RietbergenJ.B.W., HoedemaekerR.F., KrugerA.E.B., KirkelsW.J., SchroderF.H.The changing pattern of prostate cancer at the time of diagnosis: characteristics of screen detected prostate cancer in a population based screening study.J Urol1998; 161: 1192–8.
15.
PoundC.R., PartinA.W., EisenbergerM.A., ChanD.W., PearsonJ.D., WalshP.C.Natural History of Progression After PSA Elevation Following Radical Prostatectomy.JAMA.1999; 281(17): 1591–7.
16.
BottS.R.J., KirbyR.S.Avoidance and management of positive surgical margins before, during and after radical prostatectomy.Prostate Cancer and Prostatic Diseases2002; 5: 252–63.
17.
CoelhoR.F., ChauhanS., OrvietoM.A., PalmerK.J., RoccoB., PatelV.R.Predictive Factors for Positive Surgical Margins and Their Locations After Robot-Assisted Laparoscopic Radical Prostatectomy.European Urol2010; 57: 1022–9.
18.
ChinJ.L., SrigleyJ., MayhewL.A., RumbleB., CrossleyC., HunteA., FleshnerN., BoraB., McLeodR., McNairS., LangerB., EvansA.Guideline for optimization of surgical and pathological quality performance for radical prostatectomy in prostate cancer management: evidentiary base.Can Urol Assoc J2010; 4: 13–25.
19.
MyersR.P.Practical surgical anatomy for radical prostatectomy.Urol Clin North Am2001; 28: 473–90.
20.
MyersR.P., Structure of the adult prostate from a clinician's standpoint.Clin Anat2000; 13: 214–5.
21.
MyersR.P.Male urethral sphinteric anatomy and radical prostatectomy.Urol Clin North Am1991; 18: 211–27.
22.
LissM., OsannK., OrnsteinD.Positive surgical margins during robotic radical prostatectomy: a contemporary analysis of risk factors.BJU Int2008; 102: 603–7.
23.
MastersonT.A., BiancoF.J.J., VickersA.J., DiBlasioC.J., FearnP.A., RabbaniF., EasthamJ.A., ScardinoP.T.The Association Between Total and Positive Lymph Node Counts, and Disease Progression in Clinically Localized Prostate Cancer.J Urol2006; 175: 1320–5.
ThurairajaR., StuderU.E., BurkhardF.C.Indications, Extent, and Benefits of Pelvic Lymph Node Dissection for Patients with Bladder and Prostate Cancer.The Oncologist2009; 14: 40–51.
26.
Kleve kaV., MuschM., RoggenbuckU., StoerkelS., KroepfD.The incidence of lymph node metastases in prostate carcinoma depends not only on tumor characteristics but also on surgical performance and extent of pelvic lymphadenectomy.Medicina (Kaunas)2008; 44: 601–8.
27.
GalvinD.J., EasthamJ.A.Critical appraisal of outcomes following open radical prostatectomy.Curr Opin Urol2009 May; 19: 297–302.
28.
LeeJ.W., JeongW.J., ParkS.Y., LoreazoE.I.S., OhC.K., RhaK.H.Learning Curve for Robot-Assisted Laparoscopic Radical Prostatectomy for Pathologic T2 Disease.Korean J Urol2010; 51: 30–3.
